loadpatents
name:-0.039221048355103
name:-0.035567998886108
name:-0.0010249614715576
Perricaudet; Michel Patent Filings

Perricaudet; Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Perricaudet; Michel.The latest application filed is for "recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same".

Company Profile
0.29.35
  • Perricaudet; Michel - Ecrosnes FR
  • Perricaudet; Michel - Escrosnes N/A FR
  • Perricaudet; Michel - Ecrignolles FR
  • Perricaudet; Michel - Paris FR
  • Perricaudet; Michel - 28320 Ecrosnes FR
  • Perricaudet, Michel - Ouarville FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Adenovirus vaccine vectors
Grant 9,862,931 - Benihoud , et al. January 9, 2
2018-01-09
Recombinant adenoviruses encoding the specific iodine transporter (NIS)
Grant 8,642,028 - Perricaudet , et al. February 4, 2
2014-02-04
Recombinant Viruses And Their Use For Treatment Of Atherosclerosis And Other Forms Of Coronary Artery Disease And Method, Reagent, And Kit For Evaluating Susceptibility To Same
App 20130210898 - BENOIT; Patrick ;   et al.
2013-08-15
Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to Same
App 20130164262 - Benoit; Patrick ;   et al.
2013-06-27
Adenovirus vaccine vectors
App 20130164327 - Benihoud; Karim ;   et al.
2013-06-27
Recombinant Adenoviruses Encoding The Specific Iodine Transporter (nis)
App 20120269773 - PERRICAUDET; Michel ;   et al.
2012-10-25
Inhibition of the liver tropism of adenoviral vectors
App 20090280089 - Benihoud; Karim ;   et al.
2009-11-12
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
App 20090257981 - Benoit; Patrick ;   et al.
2009-10-15
Defective recombinant adenoviruses expressing cytokines for antitumor treatment
Grant 7,306,793 - Haddada , et al. December 11, 2
2007-12-11
Recombinant adenoviruses for gene therapy in cancers
Grant RE39,078 - Dedieu , et al. April 25, 2
2006-04-25
Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
Grant 7,033,826 - Perricaudet , et al. April 25, 2
2006-04-25
Targeted adenovirus vectors for delivery of heterologous genes
App 20060002893 - Vigne; Emmanuelle ;   et al.
2006-01-05
Adenovirus including a gene coding for a superoxide dismutase
App 20050244381 - Mallet, Jacques ;   et al.
2005-11-03
Targeted adenovirus vectors for delivery of heterologous genes
Grant 6,911,199 - Vigne , et al. June 28, 2
2005-06-28
Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)
App 20050069523 - Horellou, Philippe ;   et al.
2005-03-31
Defective recombinant adenoviruses expressing cytokines for antitumor treatment
App 20050048031 - Haddada, Hedi Mohamed ;   et al.
2005-03-03
Medicinal combination useful for in vivo exogenic transfection and expression
App 20040265276 - Perricaudet, Michel ;   et al.
2004-12-30
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
App 20040265273 - Li, Hong ;   et al.
2004-12-30
Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
App 20040224409 - Pradier, Laurent ;   et al.
2004-11-11
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
Grant 6,814,962 - Benoit , et al. November 9, 2
2004-11-09
Defective recombinant adenoviruses expressing cytokines for antitumor treatment
Grant 6,811,774 - Haddada , et al. November 2, 2
2004-11-02
Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
Grant RE38,556 - Benoit , et al. July 13, 2
2004-07-13
Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain
Grant 6,756,523 - Kahn , et al. June 29, 2
2004-06-29
Viral recombinant vectors for expression in muscle cells
Grant 6,743,623 - Perricaudet , et al. June 1, 2
2004-06-01
Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein
Grant 6,696,420 - Perricaudet , et al. February 24, 2
2004-02-24
Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)
Grant 6,685,934 - Mallet , et al. February 3, 2
2004-02-03
Defective adenoviruses including a therapeutic gene and an immunoprotectove gene
Grant 6,669,942 - Perricaudet , et al. December 30, 2
2003-12-30
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
Grant 6,638,502 - Li , et al. October 28, 2
2003-10-28
Generating replicating molecules in vivo
Grant 6,630,322 - Perricaudet , et al. October 7, 2
2003-10-07
Targeted adenovirus vectors for delivery of heterologous genes
App 20030143209 - Vigne, Emmanuelle ;   et al.
2003-07-31
Defective adenovirus vectors and use thereof in gene therapy
App 20030096787 - Perricaudet, Michel ;   et al.
2003-05-22
Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
App 20030086907 - Briand, Pascale ;   et al.
2003-05-08
Recombinant Adenoviral Vectors For Human Tumour Gene Therapy
App 20030082150 - BOON-FALLEUR, THIERRY ;   et al.
2003-05-01
Adenovirus Including A Gene Coding For A Superoxide Dismutase
App 20030059455 - BARKATS, MARTINE ;   et al.
2003-03-27
Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
App 20030039634 - Perricaudet, Michel ;   et al.
2003-02-27
Method for producing recombinant virus
App 20030022356 - Leblois-Prehaud, Helene ;   et al.
2003-01-30
Medicinal Combination Useful For In Vivo Exogenic Transfection And Expression
App 20030004091 - PERRICAUDET, MICHEL ;   et al.
2003-01-02
Adenovirus-mediated transfer of genes to the lung
App 20020164304 - Crystal, Ronald G. ;   et al.
2002-11-07
Viral Recombinant Vectors For Expression In Muscle Cells
App 20020122789 - PERRICAUDET, MICHEL ;   et al.
2002-09-05
Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter
Grant 6,426,216 - Perricaudet , et al. July 30, 2
2002-07-30
Recombinant Adenoviruses Containing An Inducible Promoter Controlling A Gene Of Viral Origin
App 20020098165 - PERRICAUDET, MICHEL ;   et al.
2002-07-25
Gene therapy for restenosis using an adenoviral vector
App 20020094324 - Branellec, Didier ;   et al.
2002-07-18
Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin
Grant 6,420,170 - Perricaudet , et al. July 16, 2
2002-07-16
Gene therapy for restenosis using an adenoviral vector
Grant 6,410,011 - Branellec , et al. June 25, 2
2002-06-25
Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
App 20020068052 - Briand, Pascale ;   et al.
2002-06-06
Recombinant Adenoviruses And Use Thereof In Gene Therapy For Treating Eye Diseases
App 20020064870 - BRIAND, PASCALE ;   et al.
2002-05-30
Method for producing recombinant virus
Grant 6,387,670 - Leblois-Prehaud , et al. May 14, 2
2002-05-14
Recombinant Adenoviruses Coding For Glial-derived Cell Neurotrophic Factor (gdnf)
App 20020031493 - HORELLOU, PHILIPPE ;   et al.
2002-03-14
Defective Recombinant Adenoviruses Expressing Cytokines For Antitumor Treatment
App 20020031499 - HADDADA, HEDI ;   et al.
2002-03-14
Recombinant Viruses Coding For A Glutamate Decarboxylase (gad) Activity
App 20020028212 - GEOFFROY, MARIE-CLAUDE ;   et al.
2002-03-07
Adenoviral Vectors For Mutants Of Human Interleukin 6 (hil-6) With Hil-6 Antagonist Activity, Pharmaceutical Compositions Therewith And Their Uses
App 20020012656 - CILIBERTO, GENNARO ;   et al.
2002-01-31
Defective Adenoviruses Including A Therapeutic Gene And An Immunoprotective Gene
App 20020006395 - PERRICAUDET, MICHEL ;   et al.
2002-01-17
Viable contaminant particle free adenoviruses, their preparation and use
App 20010039046 - Yeh, Patrice ;   et al.
2001-11-08
Adenoviral vectors of canine origin
Grant 6,294,377 - Haddada , et al. September 25, 2
2001-09-25
Cells for the production of recombinant adenoviruses
Grant 6,127,175 - Vigne , et al. October 3, 2
2000-10-03
Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
Grant 6,033,885 - Latta , et al. March 7, 2
2000-03-07
Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
Grant 6,013,638 - Crystal , et al. January 11, 2
2000-01-11
Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
Grant 5,866,551 - Benoit , et al. February 2, 1
1999-02-02
Recombinant adenoviruses for gene therapy in cancers
Grant 5,837,531 - Dedieu , et al. November 17, 1
1998-11-17
Method for preparing recombinant adeno-associated viruses (AAV), and uses thereof
Grant 5,789,390 - Descamps , et al. August 4, 1
1998-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed